Profil
Mr. Ketan B. Mehta is a Chief Executive Officer at Tris Pharma, Inc. He is on the Board of Directors at Park Therapeutics, Inc. Mr. Mehta was previously employed as an Independent Director by Aytu BioScience, Inc. He received his graduate degree from the University of Oklahoma.
Postes actifs de Ketan Mehta
| Sociétés | Poste | Début |
|---|---|---|
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Directeur Général | 01/01/2000 |
Park Therapeutics, Inc.
Park Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of pain | Directeur/Membre du Conseil | - |
Anciens postes connus de Ketan Mehta
| Sociétés | Poste | Fin |
|---|---|---|
| AYTU BIOPHARMA, INC. | Directeur/Membre du Conseil | 19/03/2021 |
Formation de Ketan Mehta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Oklahoma
University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Aytu Biopharma, Inc.
Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Park Therapeutics, Inc.
Park Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of pain | Health Technology |
















